Legis Daily

Expressing the fact that the House of Representatives supports the system for prescription drug coverage provided under part D of the Medicare program and believes that changes to such system should not be part of the American Health Care Act of 2017.

USA115th CongressHRES-215| House 
| Updated: 3/24/2017
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (1)
Brian J. Mast (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Expresses: (1) support for the Medicare prescription drug benefit, and (2) the belief that changes to the benefit should not be included in the American Health Care Act of 2017.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 21, 2017
Introduced in House
Mar 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 23, 2017
Referred to the Subcommittee on Health.
Mar 24, 2017
Referred to the Subcommittee on Health.
  • March 21, 2017
    Introduced in House
  • March 21, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • March 23, 2017
    Referred to the Subcommittee on Health.
  • March 24, 2017
    Referred to the Subcommittee on Health.

Health

Health care costs and insuranceHealth care coverage and accessMedicarePrescription drugs

Expressing the fact that the House of Representatives supports the system for prescription drug coverage provided under part D of the Medicare program and believes that changes to such system should not be part of the American Health Care Act of 2017.

USA115th CongressHRES-215| House 
| Updated: 3/24/2017
Expresses: (1) support for the Medicare prescription drug benefit, and (2) the belief that changes to the benefit should not be included in the American Health Care Act of 2017.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 21, 2017
Introduced in House
Mar 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 23, 2017
Referred to the Subcommittee on Health.
Mar 24, 2017
Referred to the Subcommittee on Health.
  • March 21, 2017
    Introduced in House
  • March 21, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • March 23, 2017
    Referred to the Subcommittee on Health.
  • March 24, 2017
    Referred to the Subcommittee on Health.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (1)
Brian J. Mast (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care costs and insuranceHealth care coverage and accessMedicarePrescription drugs